CICC Starts Jiangsu Sinopep-Allsino Biopharmaceutical at Outperform With 88 Yuan Price Target
Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$30.65 From HK$32.69, Keeps at Neutral
Nomura Adjusts WuXi AppTec's Price Target to HK$43.45 From HK$54.56, Keeps at Buy
Nomura Adjusts Aier Eye Hospital's Price Target to 13.70 Yuan From 15.35 Yuan, Keeps at Buy
UOB Kay Hian Upgrades Guangzhou Kingmed Diagnostics to Buy From Hold; Price Target Is 35 Yuan
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 107.91 Yuan From 118.48 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$76.45 From HK$83.94, Keeps at Buy
Nomura Adjusts Joinn Laboratories' Price Target to 12.27 Yuan From 17.37 Yuan, Keeps at Neutral
Morgan Stanley Downgrades Aier Eye Hospital to Underweight From Equal-weight; Price Target Is 9.80 Yuan
Goldman Sachs Downgrades Aier Eye Hospital to Neutral From Buy; Price Target Is 15 Yuan
Nomura Adjusts Pharmaron's Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy
Nomura Adjusts Aier Eye Hospital's Price Target to 15.35 Yuan From 22.14 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories' Price Target to 118.48 Yuan From 127.21 Yuan Keeps at Buy
Nomura Adjusts Wuxi Apptec's Price Target to 62.75 Yuan From 99.16 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories Tianjin's Price Target to HK$90.12 From HK$134.59, Keeps at Buy
Nomura Adjusts Aier Eye Hospital Group's Price Target to 22.14 Yuan From 25.03 Yuan, Keeps at Buy.
Nomura Downgrades Joinn Laboratories (China) to Neutral From Buy, Adjusts Price Target to HK$12.60 From HK$20.93
Nomura Adjusts Pharmaron's Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy
Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$134.59 From HK$130.30, Keeps at Buy
Nomura Adjusts Joinn Laboratories (China)'s Price Target to HK$20.93 From HK$20.64, Keeps at Buy